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Abstract 
In the framework of the 2015 D3R inaugural grand challenge, blind binding pose and 
affinity predictions were performed for a set of 180 ligands of the Heat Shock Protein 
HSP 90- protein, a relevant cancer target. Spectral clustering was used to rapidly 
identify alternative binding site conformations in publicly available crystallographic 
HSP90-alpha structures.  Subsequently, multiple docking and scoring protocols 
employing the software Autodock Vina and rDock were applied to predict binding 
modes and rank order ligands. Alchemical free energy calculations were performed with 
the software FESetup and Sire/OpenMM to predict binding affinities for three 
congeneric series subsets. Some of the protocols used here were ranked among the top 
submissions according to most of the evaluation metrics. Docking performance was 
excellent, but the scoring results were disappointing. A critical assessment of the results 
is reported, as well as suggestions for future similar competitions. 
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1. Introduction  
Since the advent of computer-aided drug design (CADD) in the early 1980s a major 
goal of the field has been the quantitative prediction of protein-ligand interactions. 
Though CADD is now a major technique deeply entrenched in drug discovery [1–9], 
molecular modelling protocols that reliably and quantitatively predict precise 
biophysical measurements remain sought after. Obstacles are well understood and 
include limits in the accuracy of potential energy functions [10–13], and accounting of 
possible conformational changes in protein and ligands upon complexation [14–19]. 
While numerous methodologies have been proposed to address these challenges, initial 
evaluation typically relies on retrospective analysis of their performance. Though such 
practice is necessary to initiate methodological work, it is insufficient to validate 
techniques for application to drug discovery. The chief objection is that it is difficult to 
guarantee removal of biases in the selection of optimal and transferable protocol 
parameters. A more realistic assessment of the performance of molecular modelling 
protocols should include true predictions that are subsequently corroborated by follow-
up experimental measurements. Yet a major difficulty that stands in the way of this 
scenario is that most academic labs that contribute innovative CADD methodologies are 
ill-equipped to follow-up predictions with adequate experimental measurements. To 
address this obstacle, the 2015 D3R’s (Drug Design Data Resource) inaugural grand 
challenge was setup by a consortium of academics and pharmaceutical companies to 
assess the state of the art of molecular modelling protocols with blinded predictions of 
binding poses and binding affinities of drug-like small molecules on previously 
undisclosed relevant datasets contributed by the pharmaceutical industry. 
Structured as a two-stage contest, the first D3R grand challenge aimed to put different 
computational approaches to the test to predict binding modes and binding affinities. 
This report is concerned with the competition that focussed on the Heat shock protein 
HSP 90-alpha (HSP90-α) dataset. Participants were provided with a library of structures 
of putative ligands for the ATP binding site of this cancer target [20–22]. The objective 
of the first stage of the competition was to perform a blinded pose prediction on a small 
subset of six compounds of this library, and an affinity-based rank ordering for the full 
library. Participants were also given the opportunity to submit binding affinity 
predictions for subsets of this dataset. This report contrasts the performance of several 
protocols used by our group for docking and scoring this dataset and concludes with 
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suggestions for future similar competitions. All datasets discussed are available for 
download from the webpage of the Drug Design Data Resource consortium [23]. The 
supplementary information gives details on how to compare the presented work here to 
other competitors results.  
2. Theory and Methods 
2.1 Datasets 
The ligand library provided by the organizers consisted of 180 ligands based on 
different scaffolds, all provided as SMILES strings. Subsets of the 180 ligands were 
defined by the organizers as set1, 2 and 3 containing five benzophenone derivatives, 
four amino pyrimidine derivatives and ten molecules built from benzimidazolone 
scaffolds respectively. A 2D structure of each of the subsets can be found in figure SI1. 
For HSP90-α four crystal structures were provided (PDBID: 2JCC, 2XDX, 4YKR and 
4YKY), capturing two conformations of the ATP binding site of HSP90-α, although 
participants were encouraged to further evaluate the receptors conformational 
variability.  
Once the challenge was concluded the experimental affinity data was released by the 
organizers, consisting of IC50 data obtained using a FRET based assay as described by 
Huth et al. [24]. To compare computational prediction with experimental results the 
binding free energy of a ligand L2 relative to a ligand L1 was calculated with equation 
1: 
𝛥𝛥𝐺𝑳𝟏→𝑳𝟐 =𝑘𝐵Tln
IC50𝐿2
IC50𝐿1
  ,       (1) 
where kB is the Boltzmann constant, and T the temperature. 
2.2 Selection of protein structures for docking and scoring 
Initial analysis of available X-ray diffracted crystal structures of HSP90-α indicated that 
significant ligand-induced conformational changes in the ATP binding site were 
possible [25,26]. Given the relatively short period available for contestants to submit 
predictions it was deemed unpractical to initiate binding site conformational dynamics 
studies via enhanced sampling methods such as accelerated Molecular Dynamics 
[27,28] (aMD) or Metadynamics [29]. Yet the literature evidence was sufficient to 
suggest that simplistic treatments of protein flexibility for this binding site  (i.e: 
considering pre-computed rotamer libraries for flexible sidechains [30], using reduced 
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van der Waals radii on the receptor atoms [31,32], or the refinement of docking poses 
by means of Molecular Dynamics (MD) simulations [33,34]) would  fail to capture 
potential significant conformational rearrangements. The alternative pursued here was 
to analyse collections of previously solved X-ray structures to construct a representative 
ensemble of binding site conformations suitable for docking calculations [26].  
Given the large number of available HSP90- structures in public databases an 
algorithm was needed to classify structures by representative patterns. This was carried 
out with a spectral clustering method [35,36]. Specifically, 195 HSP90-α crystal 
structures from the PDB were identified with a resolution of at least 2 Å. A root mean 
square deviation (RMSD) matrix M between these 195 structures based on C-α atoms 
was then computed, see figure 1. The RMSD matrix then served as a distance matrix for 
spectral clustering. The idea behind spectral clustering is to achieve a dimensionality 
reduction of a large dataset and grouping (clustering) of similar structures in the 
process. The goal here was to find representative structures from the resulting clusters 
that would then be used for docking calculations. The RMSD matrix was used to 
formulate a Gaussian diffusion kernel which gives an artificial diffusion distance 
between the different crystal structures. The diffusion probability between two crystal 
structures is given by: 
𝑲𝒊𝒋 = 𝐞𝐱𝐩 (−
|𝑴𝒊𝒋
𝟐 |
𝟐𝜺
),         (2) 
where 𝑀𝑖𝑗  are the entries of the RMSD matrix, ε is a cutoff, and K is a matrix holding 
information about the diffusion probabilities. The cutoff ε was chosen to be 0.25 Å2. K 
can be normalized such that it is a stochastic matrix T, whose eigenvalues are the 
objects of interest for the spectral clustering. The dominant eigenvalues of T indicate 
how many clusters the dataset contains. Subsequently the so called Perron Cluster 
Cluster Analysis (PCCA+) algorithm [37], which uses information in the eigenvector 
structure to assign invariant clusters, was used to assign each of the crystal structure to 
one of the clusters. The eigenvalues of the stochastic matrix T and the PCCA+ clusters, 
were computed using the software package pyEMMA [38].  
2.3 Docking 
Docking protocols 
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PDB structures retained for further analyses were prepared for docking calculations.  
Addition of hydrogen atoms and removal of co-crystallized ligands was conducted 
using the software fconv [39]. Protonation states for titratable residues in the receptor 
were assigned using PROPKA [40,41] at a pH value of 7, while the pKA calculator 
plugin from Marvin 15.3.30.0 was used to determine the most abundant species of 
ligands at pH 7.  
Two different docking methodologies were employed. The first protocol, denoted 
‘unbiased’, was carried out using the software Autodock Vina. A cube of 20 Å of side 
was centred on Asp 93 to define the docking search space, the exhaustiveness level was 
set up at 50 and default options were used for the remaining parameters. AutodockTools 
was used to prepare the ligands and to assign Gasteiger charges [42]. The second 
protocol, denoted ‘guided’, was carried out with the software rDock [32]. In this case, 
the ‘guided’ protocol was similar to that reported by Barril and co-workers [43]. In 
brief, a hydrogen bond donor and hydrogen bond acceptor groups from the ligand were 
set to a distance of 4.0±0.75 Å from Cγ of Asp 93, which was also the centre of a sphere 
of radius 24 Å that enclosed the docking cavity. Each compound was subjected to 100 
iterations of the genetic algorithm using default scoring parameters.  
Additionally, water molecules are known to play a key role in the stabilization of 
ligands in the HSP90-α binding site [43], therefore two interstitial water molecules that 
interact with the side chain of Asp 93 were retained in both the ‘unbiased’ and the 
‘guided’ docking protocols. 
Ranking protocols 
Docking protocols employed for the pose prediction were also used for ranking of the 
whole dataset. For clarity protocols are named according to the docking program used 
(v for Autodock Vina, rd for rDock), and the PDB ID of the HSP90-α structure used for 
the dockings (4w7t, 4l94, 4cwf, 2fwz, 2ccu). This yielded 10 different ranking for the 
ligands dataset. In addition two further protocols were defined as rd/v-average(avg) and 
rd/v-best. rd/v-avg is obtained by taking the average score of the top-ranked pose from 
all five receptor structures for each of the 180 compounds. rd/v-best is obtained by 
taking the results from the best scoring structure for each of the 180 compounds. Some 
compounds were unable to satisfy the imposed restraints, and these were arbitrarily 
assigned a score of 0.0 kcal/mol. 
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2.4 Alchemical free energy simulations 
Theoretical background  
Relative alchemical free energy have shown to be a useful tool for the computational 
prediction of binding affinities in the past [11,44–50]. In this methodology, the relative 
free energy of binding for two ligands to the same receptor can be described by a 
thermodynamic cycle. Rather than using molecular dynamics (MD) simulations to 
compute binding trajectories directly for the two different ligands, an alchemical 
transformation, ‘morphing’ L1 to L2 is carried out. The relative free energy of binding 
between two ligands is then given by: 
𝛥𝛥𝐺𝑏𝑖𝑛𝑑(𝐿1, 𝐿2) =  𝛥𝐺𝑠𝑜𝑙𝑣𝑎𝑡𝑒𝑑(𝐿1, 𝐿2) − 𝛥𝐺𝑏𝑜𝑢𝑛𝑑(𝑃𝐿1, 𝑃𝐿2). (3) 
This means that in order to compute 𝛥𝛥𝐺𝑏𝑖𝑛𝑑(𝐿1, 𝐿2) two independent sets of 
simulations have to be carried out. One simulation for L1 solvated in water and one 
simulation for L1 bound to the protein. In both sets of simulations L1 is transformed to 
L2 over a set of λ ∈ [0,1] windows, where λ=0 corresponds to L1 and λ =1 
corresponds to L2, either in just solvent or solvated and complex. Any intermediate λ
value corresponds to a simulation with a linear interpolation between L1 and L2 in the 
force field. In this work a single topology alchemical perturbation protocol was 
employed, using 17 evenly spaced λ-windows. The MBAR estimator as implemented 
in pymbar was used to recover Δ𝐺𝑠𝑜𝑙𝑣𝑎𝑡𝑒𝑑  and  𝛥𝐺𝑏𝑜𝑢𝑛𝑑 values from the 17 separate λ 
simulations [51]. All simulations were carried out with the Sire/OpenMM (SOMD) 
software revision 2015.0.0. [52].   
Alchemical free energy molecular dynamics simulation setup 
The relative free energy setup and simulation protocol from the predicted docking poses 
is laid out in the following. Aside from the set 1, 2, and 3 compounds a small test 
dataset was initially simulated to validate the proposed simulation protocol for the 
challenge. The compounds of the test dataset were taken from Bruncko et al. [53]. The 
simulation setup pipeline was identical in all cases although a different representative 
structure of the receptor was used for each set. PDB structures 2YK2 [54] and 4L90 
were used for sets 1 and 3 respectively based on trial docking calculations, whereas 
PDB structures 2XDX [55], and 3OWD [53] were used for the test set and set 2 
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respectively due to the perceived similarity between the co-crystallized and query 
compounds.  
The FESetup [56] software was used to  set up relative free energy calculations  Ligands 
were automatically parameterized using the GAFF force field [57] and assigned AM1-
BCC [58,59] charges. More details for the setup parameters are provided in the SI.  
Alchemical free energy molecular dynamics simulation protocol 
Single-topology alchemical free energy calculations were carried out using the SOMD 
simulation engine with the following protocol. The CUDA OpenMM [60] platform was 
used to execute the simulations on a cluster of GTX980 GPUs. Both the complexes 
consisting of protein and ligand as well as the ligand in water were run in order to be 
able to extract a relative binding free energy from these simulations using eq. 3. Each 
simulation was repeated twice to assess reproducibility of the computed relative binding 
free energies. During all simulations a hydrogen mass repartition [61] scheme was 
employed to allow for an integration time step of 4 fs and each -simulation was run for 
8 ns using a Leap-Frog Verlet algorithm. The initial velocities were drawn randomly 
according to a Maxwell-Boltzmann distribution at 298 K. A mean temperature of 298 K 
was achieved using an Andersen thermostat with a collision frequency of 10 ps
−1
, 
whereas
 
pressure was maintained at 1 atm using a Monte Carlo barostat as implemented 
in OpenMM [62,63] with an update frequency of 25 MD steps. The simulation box was 
treated with periodic boundary conditions and non-bonded interactions were evaluated 
by using a 10 Å  atom-based Barker-Watts reaction field cut off scheme, with the 
medium dielectric constant set to εsolvent = 78.3. Simulation input files are available for 
download, with more information given in the SI.  
Alchemical free energy molecular dynamics simulation analysis 
As a first step in conducting an alchemical free energy calculation, a series of 
perturbations between ligands needs to be defined. An example of such a perturbation 
network is shown in figure 5A and can be interpreted as a directed graph, where the 
directed edges indicate the direction of simulations carried out. Each edge represents 
two sets of calculations; the changing of the ligand in solvent and the changing of the 
ligand bound to the protein. The value along the edge (in kcal/mol) is the computed 
𝛥𝛥𝐺𝑏𝑖𝑛𝑑(𝐿1, 𝐿2), based on the intermediate simulations, from equation 3. In order to 
obtain relative free energies with respect to a given reference compound, e.g. 9e from 
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figure 5A, different approaches can be taken [64] In this study a straight forward path 
averaging was used. Each of the two ‘edge simulations’ was repeated twice and an 
average of both relative binding free energies ∆∆G between the two compounds was 
computed. This resulted in an ‘averaged’ perturbation network as shown in Fig. 5A. 
Relative binding free energies of each individual run were compared before averaging 
in order to make sure that both runs resulted in a similar ∆∆G. The averaged 
perturbation network of relative binding free energies was then analysed using the 
python network package networkX [65]. Two simple checks were carried to test the 
robustness of the network before proceeding. According to Kirchhoff’s law, the sum of 
flow into a node and out of a node must be zero and simple cycles consisting of three 
nodes should therefore be zero. In practice cycles with a cycle closure error less than 0.3 
kcal/mol were considered a sign of robust convergence. Since the overall goal was to 
compute a relative binding free energy of all compounds with respect to a particular 
target compound, networkX was used to compute all possible simple paths, i.e. non-self 
crossing paths, between a target compound (e.g. node 9e of figure 5A) and an initial 
compound (e.g. 9b of figure 5A). The resulting free energy paths were averaged and 
their standard deviations used for the error analysis. Doing an analysis in this way 
neglects information on the fact that different paths will have different lengths and 
should give different contributions to the overall relative free energy between 9b and 
9e. However, it is unclear based on the assumption that all edges along the path carry a 
certain uncertainty, which may vary depending on each of the edge, what the most 
robust way of estimating relative free energies is. All relative free energies shown in the 
results section have been computed based on the path averages and their standard 
deviations based on the perturbation networks of each dataset.  
Once relative binding free energies have been computed both for the experimental data 
and from the computational perturbation network analysis, their correlation has to be 
assesed. Typical measures for correlation are the Pearson correlation coefficient R and 
Kendall τ as well as the mean unsigned error (MUE) which gives information about the 
quality of the free energy estimate. In order to test the robustness of the estimated R, τ, 
and MUE values an error analysis was undertaken in order to get a lower and upper 
bound for their estimates [46,66] . Each computational relative binding free energy 
estimate has a measured value and an error associated with it. For each computational 
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data point an artificial normal distribution was constructed, with a mean of the free 
energy estimated and the standard deviation given by the error of the estimate. Then for 
each computational data point 1000 random samples were drawn from the constructed 
normal distribution and correlated with the experimental result. This then gives 1000 
data points for R, τ and MUE, which are in turn a distribution from which the mean and 
the standard deviation can be determined and represent the values that are reported in 
the results section.   
 
3. Results and Discussion 
3.1 Receptor structure selection via spectral clustering  
During the first stage of the D3R challenge the objective was to obtain binding modes 
for six compounds, defined by the organizers, belonging to the three different chemical 
families:  two benzimidazol-2-ones (40 and 44) two hydroxibenzophenones (160 and 
175) and two aminopyrimidines (73 and 179). Given the known plasticity of the ATP 
binding site of HSP90-α, it was deemed necessary to dock each compound against 
multiple structures. Searches in the PDB returned 195 crystal structures with resolution 
< 2 Å. Although performing docking calculations on all such structures was feasible, 
this was not judged suitable given short-comings in scoring, and the increased human 
time needed for analysis of the results. Instead spectral clustering using a C-α RMSD 
metric was used to identify groups of highly related structures (see methods). The 
results indicated five dominant eigenvalues; hence the choice of five different binding 
site RMSD families seemed appropriate. After visual inspection, however, the first three 
clusters were unified, since their structural difference were not very large, and both 
cluster 1 and cluster 2 initially only held a small number of crystal structures, all 
stemming from the same crystallographic study [53]. As shown in figure 1, the final 
clustering groups the 195 structures into three large families differing in the 
arrangement of the region encompassed between residues 104 and 111:  The first cluster 
(c1) groups structures where these residues form a loop that occludes the binding site. 
The second cluster (c2) represents a conformation where the same region forms an α-
helix. The remaining cluster (c3) gathers structures where residues 104 to 111 are 
arranged in a configuration that retained features from both α-helix and disordered loop 
and where the ATP binding site is only partially occluded. It is worth noting that, 
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although the clustering procedure was solely based on the analysis of the C-α RMSD 
matrix, and no constraints were imposed regarding the final number of clusters, the 
resulting three clusters agree well with the three major conformational states of HSP90-
α (open, closed and helical) previously reported in the literature [25,26].  
Representative structures for each cluster where then selected after visual inspection. 
Care was taken to represent sidechain rearrangements not captured by the C- RMSD 
metric. Noticeably, only residues LYS58 and ASP54 were identified in two 
significantly different conformations in clusters c1 and c2, but not among structures in 
cluster c3. Consequently, structures ID:2ccu [67] and ID:4l94 [68] were used to 
represent c1, 2fwz [69] and 4cwf [70] to represent c2 and 4w7t [71] was the 
representative structure of c3. Therefore, solely by means of binding site RMSD 
spectral clustering and a slight refinement of the results, it was possible to capture major 
differences in the receptor’s binding site and to represent the whole available 
crystallographic data in a reduced data set. 
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Figure 1. A) Structure of the complex between HSP90- α and ADP (PDB ID: 1byq[72]). 
Regions of highest variability on the active site among HSP90-α crystals are highlighted in 
orange, including residues ASP54 and LYS58. B) RMSD matrix of 195 crystal structures of 
HSP90-α, with entries ordered according to the spectral clusters. The conformational difference 
between the three chosen clusters is highlighted in the top structures in orange.  
3.2 Pose prediction results  
A total of thirteen different predictions were generated using the protocols described in 
the methods section. Each prediction included up to five ranked poses. In addition to the 
protocols used to rank compounds, solely for the pose prediction part of the challenge, 
two protocols involved manual selection of the top 5 poses by visual inspection of the 
top docked poses across all tested structures (denoted –visual hereafter). In this 
protocol, the criteria followed to rank docking poses was based on the shape 
complementarity between each docking pose and the binding site, the chemical 
complementarity between ligand substituents and binding site lining sidechains 
(specially the number of hydrogen bonds established and the distances predicted by the 
docking program) and the overall resemblance of the docking pose with the 
crystallographic binding mode of related compounds. The quality of each prediction 
was evaluated by the D3R organizers using two metrics: the mean RMSD of the top 
ranked pose to the crystal structure, and the mean value of the lowest RMSD among the 
five poses belonging to each compound. A comparison of the performance of individual 
predictions is shown in figure 2. 
In general, among protocols with no a posteriori human driven refinement, protocols 
based on rDock outperform those based on Vina when results are ranked according to 
the RMSD of the top ranked pose: four out of six rDock protocols achieved RMSD 
values below 2.5 Å in this metric, while in the case of Vina protocols all scored above 
3.0 Å. The same trend is observed when results are ranked according to the lowest 
RMSD obtained within the top 5 ranked poses, although differences become less 
evident in this case: all rDock protocols scored below 2.5 Å while four out of six Vina 
protocols were below that threshold. Due to the small number of predictions, which 
does not allow for a significant statistical analysis, these results do not report on the 
quality of any of the codes or scoring functions. Instead, it is assumed that the better 
performance of protocols employing rDock highlights that the use of pharmacophoric 
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restraints enables a more accurate sampling of region of interest of the conformational 
space. Indeed, this explains why reduced differences between rDock and Vina protocols 
are observed when predictions are ranked according to the lowest RMSD of any top 5 
ranked poses. The correct pose is also sampled by the protocols based on Vina but it is 
wrongly ranked. By contrast, the use of pharmacophoric restraints avoids exploring 
solutions away from the region of interest, and allows a more exhaustive exploration of 
the local minima, produced more refined poses that score better. 
 
Figure 2. Bar plot of all different Docking protocols and the mean RMSD of the best submitted 
pose (green) and beast mean RMSD from all submissions (blue).  
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The best overall performance was obtained by the rDock-visual protocol, were a 
prediction was produced after visual inspection of top scored poses across multiple 
structures (unfortunately the equivalent Vina protocol was not ranked by the organizers 
due to a formatting error for our submission. Similar results were expected due to the 
high resemblance of the predicted poses with the rDock-visual and Vina-visual 
protocols). Precisely, the mean RMSD of the first pose for the rDock-visual protocol 
was 1.2 Å (ranking 4th out of 47 submissions in the challenge).  As shown in figure 4 
this protocol yielded predictions with an RMSD below 1.0 Å for four compounds (73, 
164, 40 and 179), slightly above for 175 and only for 44 the RMSD peaked above 3.0 
Å. Even in the case of 44, the main features of the binding mode were retained and the 
high RMSD value is due to a different orientation of the pyridine sulphonamide moiety. 
It is worth emphasing that this human driven protocol outperformed automated docking 
predictions on single structures, as well as automated consensus protocols. 
 
 
Figure 3. Superposition and RMSD performance of the rd-visual protocol prediction of query 
compounds with respect to their revealed crystal structure.  
Scoring of compounds 
Similarly to the evaluation of the pose prediction stage, performance of the different 
scoring protocols was assessed using three different metrics: the area under curve 
(AUC) of a receiver operator curve (ROC), the Pearson correlation coefficient (R value) 
and Kendall τ. The first metric reports on the ability of a protocol to distinguish active 
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(defined as those compounds with an IC50 < 1 μM) from inactive compounds, while 
the other two metrics assess the correlation of the rankings between experimental and 
docking results for the 180 compounds. To assess statistical treatment, the data was 
bootstrapped and for each docking dataset of the 180 ranked compounds, a ‘new’ set of 
180 compounds was drawn at random with replacement from the existing dataset and 
ordered according to their rank obtained from the docking program. Figure 4 
summarises the overall results of the scoring of the 180 ligands using the different 
protocols. From figure 4A it can be deduced, that three of the rDock protocols (rd-best, 
rd-avg, and rd-4w7t) performed significantly better than the other rDock and Autodock 
Vina protocols for the AUC measure. All Autodock Vina protocols perform similarly 
and the best average AUC value obtained is 0.72. The overall correlation between the 
rankings of compounds is rather poor for both the R value and the Kendall τ measure. 
Figure 4B and 4C show that only the rDock protocol rd-4l94 performs significantly 
worse. This poorer performance may be due to the different arrangement of the side 
chains of LYS58 and ASP54 in this crystal structure. In comparison to other 
participants of the challenge, both correlation scores lead to a top 3 position rank. 
However, there is no statistically significant difference with other top scoring protocols, 
largely due to an overall poor correlation. 
Interestingly, nine compounds were excluded from the ‘guided’ docking protocol since 
they could not satisfy the imposed pharmacophoric restraints. Among these, compounds 
51, 122, 180, and 182 were later revealed to be inactive (IC50 >> 1 M); two other (145 
and 165) were found to be ~100 fold less active than the most potent inhibitor in the 
dataset (44, IC50 = 0.005 M). The remaining three compounds 128, 161 and 174 
belong to the top 10% of most potent inhibitors. Therefore, although AUC measure was 
significantly better for the ‘guided’ docking protocols, this family of protocols failed to 
identify three interesting compounds that arguably deviated significantly from other 
scaffolds in the dataset (Figure SI4).  
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Figure 4. Scoring Results. Autodock protocols are shown in blue and rDock protocols in green. 
Mean and 95% confidence intervals are shown. A) Area under Curve of 1000 bootstrapped 
ROC curves. B) R metric. C) Kendall  metric.  
  
17 
 
 
3.2 Alchemical relative free energy calculations 
Test data set – amino pyrimidine scaffolds 
The robustness of the proposed simulation and analysis protocol was first tested on a 
small dataset of amino pyrimidine derivatives for which both crystal structure data, as 
well as IC50 data from a FRET assay were available [53]. The results of the test data set 
are summarized in figure 5. Figure 5A shows the relative alchemical calculations 
carried out, needed for the computation of relative binding free energies with respect to 
a reference compound, here compound 9e. Errors on the computed ΔΔG values are 
omitted for clarity in figure 5A, but can be found in table SI1. Figure 5B shows the 
results of the experimentally obtained ΔΔGexp with respect to the computational 
results. Trends are correctly captured apart from one compound (9b). The correlation 
between the computational and experimental estimate are analysed computing the 
Pearson rank correlation coefficient R, as well as Kendall τ. A relatively good 
correlation of R=0.74±0.03 and τ= 0.79±0.04, is observed. A third measure that was 
used is the mean unsigned error (MUE) which after bootstrapping had a clear maximum 
in its distribution given by MUE = 1.2±0.1 kcal/mol. Since the test dataset gave 
reasonable confidence in the implemented protocol the same protocol and analysis 
method were employed for blind predictions of the D3R datasets.  
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Figure 5. A) Perturbation network of the test dataset. Directional arrows indicated simulations 
carried out with computed relative free energies in [kcal/mol]. Green numbers indicate average 
cycle closure errors. B) Experimental versus computational relative binding free energies with 
respect to compound 9e. Dashed line represents optimal agreement between experiments and 
computations.  
 
Set 2 – Amino pyrimidine scaffolds 
Results of the dataset defined as set 2 by the D3R competition are shown in Figure 6. 
As before, the relative free energy values shown are obtained from the average network 
taken from two independent runs and a more detailed table summarising all relative 
binding free energies including error estimates can be found in table SI2 and SI3. 
Although crystallographic water molecules found in PDB ID: 2xdx were retained during 
alchemical free energy simulations, the results submitted to the D3R challenge included 
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data in which compound 100 was set up with only two interacting crystal water 
molecules in the binding site, due to a clash with the nitrile group of the compound with 
a third crystal water molecule as shown in figure 6C and figure 6D. The clashing water 
was carelessly deleted during the challenge phase when preparing the setup. However, 
this resulted in a very poor prediction for the relative binding free energies of all 
compounds in set 2. This is illustrated in figure 6B, where the red bars represent the 
experimental results and the blue bars computed relative binding free energies based on 
calculations, where simulations starting from compound 100 were simulated with two 
waters in the binding pocket, while simulations starting from all other compounds were 
simulated with three waters in the binding site. A scatter plot of the same data can be 
found in figure SI2. The resulting sampled R value of R = -0.6±0.2 shows a negative 
correlation and a MUE = 3.3±0.2 kcal/mol, clearly indicating that the computational 
prediction does not capture experimental trends. Organizers also computed the RMS 
error as a measure of performance and found this to be 2.0 kcal/mol, ranking this result 
10
th
 out of 18 submissions. Upon further inspection, it was evident that no water 
molecule diffuses into the binding pocket during the 8 ns-per  simulations starting 
from compound 100. Effectively, this meant that compounds morphing from compound 
100 structure were lacking a potentially essential water molecule for the ligand 
stabilisation in the binding pocket. Simulations were repeated after the challenge 
deadline with three crystal waters in the binding pocket with compound 100 bound, as 
seen in figure 6D. As a result, the trend in the relative binding free energy for all 
compounds improves significantly, with an R value of R = 0.5±0.2 and a MUE = 
2.3±0.2 kcal/mol. Nevertheless, this is still a rather poor result for the overall accuracy 
of the prediction and, even though the improved results would rank the entry based on 
the R value as a top entry, it is unclear that it would classify as statistically significantly 
better than other submissions. However, these results highlight that influence of crystal 
waters in the binding pocket cannot be underestimated. While this has been shown 
elsewhere [73], and methodologies to predict water content and changes in water 
network energetics have been developed [74,75], it remains challenging to anticipate a 
priori whether changes in water structure will play a role for a given alchemical free 
energy calculation.   
20 
 
 
 
Figure 6. A) Alchemical perturbation network for set 2 with relative binding free energies 
indicated in kcal/mol. Compounds 100a is an artificially introduced intermediate. B) results of 
the computed relative binding free energies with respect to compound 100, with experimental 
results in red, and simulation results for 100 setup with 2 binding pocket waters in blue and 3 
binding pocket waters in green. Errors are shown in terms of a standard deviation and R values 
for the two crystal and three crystal water setup are indicated. C) setup with crystal water 
resulting in clash with nitrile group D) binding pocket setup of compound 100 with two crystal 
waters, by simply removing clashing water. E) setup with three waters, by manually moving the 
clashing crystal water.   
Set 3 – Benzimidazolone scaffolds 
Set 3 consists of 10 compounds and the results of the free energy predictions can be 
found in figure 7. For the case of two compounds (28 and 23) two alternative binding 
modes, shown in panels B and C of figure 7, were simulated. In each case, the binding 
mode that gave the lower relative free energy was chosen for the submission. Figure 7A 
shows the correlation between the experimental and computational predictions. The 
perturbation network for the set 3 compounds is provided shown in figure SI2 and error 
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estimates for relative calculations in table SI3. During the challenge phase not all free 
energy computations converged well with some MBAR error estimates that were much 
larger than typically seen, hinting at a sampling problem. Furthermore, it was not 
possible to reliably incorporate compound 60 into the perturbation network, due to large 
perturbations required from small intermediates as seen in the perturbation network. 
Also not all cycles gave good estimates on the cycle closure error test: for example 
including two of the cycles that involve the intermediate INT01 as seen in the 
perturbation network shown in figure SI2, with a closure error of >> 0.3 kcal/mol. With 
this information it was expected that the results would not give an excellent correlation 
with respect to the experimental values. Nonetheless a correlation of R = 0.43±0.03, τ
=0.3±0.04 and a MUE = 1.3±0.04 kcal/mol was achieved. Overall this meant a top three 
ranking with respect to all 20 submissions for this dataset in terms of R, and a best 
ranking in terms of root mean square error, which was calculated by the organisers to be 
1.43 kcal/mol. However, this result does not hold statistical scrutiny, and other top 
scoring entries fared similarly well. 
Set 1 – Benzophenone scaffolds 
Results for set 1 are summarized in figure 8. It is clear that no correlation between the 
experimental and computational data is observed, with R=-0.44±0.03, MUE=3.78±0.08 
kcal/mol, and τ=-0.55±0.09. Therefore, it was rather surprising that, despite these poor 
results, this submission was ranked in 12
th
 place out 44 submissions, according to the 
organizer computed RMS error of 2.67 kcal/mol. With the present simulation data it is 
hard to confirm the exact reason why the implemented alchemical protocol shows such 
poor performance for set 1. However, two different factors may contribute to this: first 
being the lack of available crystal structures for this data set and second its 
unsuitableness for a relative free energy calculation due to moving from a furanyl 
moiety (compound 80) to a benzyl substituent (all other compounds). To the best of our 
knowledge, no crystallographic structure has been solved for any of the compounds in 
this set, hence pose prediction was obtained purely from docking calculations.  
Moreover, the high symmetry of the compounds poses an additional difficulty, since the 
most favourable binding mode will be determined by subtitle differences in the 
accommodation of very similar hydrophobic moieties that would be hardly captured by 
docking scoring functions. Therefore, similarly to set 3, this set faced the problem of 
multiple possible binding poses for each of the compounds. Thus, each compound had 
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to be simulated using three different binding poses. The full perturbation network for set 
1 with 2D representations of the different binding poses is shown in figure SI3. In 
contrast with the previous set, the approach of choosing the binding pose that will give 
the overall most negative relative binding free energy does not yield a good correlation 
with experimental results. This observation is in line with a recent reported from Kaus 
et. al. [76]. The reason why perturbations from a five membered ring to a six membered 
ring are difficult is because they can currently only be achieved with the software 
SOMD via intermediates with neither of the rings present, such as structure INT02. 
Since two intermediates are needed, additional uncertainty in the relative free energies 
is introduced. This is especially relevant for this set since some of the paths to the 
reference compound include up to five intermediate calculations. Further analysis and 
possibly additional simulations for the dataset are desirable to establish why the 
protocol fared poorly. However, without further experimental evidence to validate the 
correctness of the predicted binding modes it is difficult to isolate errors introduced by 
the docking step and the scoring step of the competition.  
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Figure 7. A) Comparison of experimental and computed relative binding free energies for set 3. 
Compounds numbers are indicated. B) Chosen binding pose for submission C) additional 
proposed binding pose which was also simulated, for a detailed perturbation map see figure 2 of 
the SI.  
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Figure 8. Comparison of experimental relative binding free energies with respect to 
computational binding free energies for set 1 data. Compounds are indicated.  
5. Conclusions 
Accounting for receptor flexibility is still one of the unsolved challenges in docking for 
drug design. Often time tight timelines or limited computational resources prevent 
undertaking an exhaustive conformational analysis of the receptor.  When sufficient 
experimental data is available, it is possible to obtain valuable insights into protein 
flexibility by analysis of crystallographic structures. The visual inspection and 
classification of hundreds of structures, however, is a tedious and error prone task that 
can be quite time consuming. Here spectral clustering was employed to easily group 
together crystallographic structures with common features, and to aid in the 
identification of representative structures that capture most of the relevant 
conformational states of a protein binding site. Once a set of suitable structures has been 
identified, the second problem to overcome is to elucidate the binding mode of query 
compounds. The present results support the use of pharmacophoric restraints to speed 
up calculations and to yield more accurate predictions. Parsimonious use is wise since 
ill-chosen restraints will prevent docking of novel interesting scaffolds.  
On the scoring side, some of the docking protocols reported here performed well 
relative to the rest of the competition, but the absolute performance was poor. The result 
mirrors the experience of many groups and warrants further research into more accurate 
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scoring methodologies, for instance alchemical free energy calculations. In general, 
retrospective analyses are commonly used to assess the performance of binding free 
energy prediction methods. An unexpected result was the low transferability of the 
performance of the binding free energy prediction protocol from the test set to the actual 
D3R sets. Such result may highlight the sensitivity of alchemical free energy 
calculations to factors such as the number of water molecules in the binding site, or 
deviations from the correct ligand binding mode. This information can be inferred easily 
when simulations are initiated from an X-ray structure of a protein-ligand complex. 
When predictions concern novel scaffolds, correct anticipation of the most likely 
binding mode may be much harder. Consequently, future expansion of the field should 
not only focus on the development of more accurate methods for free energy 
calculation, but also deliver new approaches for reliable pose predictions that account 
for water networks and protein flexibility.  
The D3R grand challenge, together with the CSAR benchmark exercise [77–79], 
is one of the first attempts to promote blind predictions on datasets donated by the 
pharmaceutical industry. Since this situation more closely resemble the tasks faced by 
molecular modellers, blinded predictions should ideally be used more routinely to 
evaluate the performance of novel docking or scoring methodologies. However, it can 
be difficult to learn from a failure when sources of error are multiple and intricate. For 
instance, in this particular challenge it was difficult to determine whether failures in 
scoring the three compounds subsets with free energy methods was due to errors in 
binding mode predictions, or force fields employed. Another concern is the relatively 
small number of compounds present in the three subsets that were evaluated with free 
energy methods. Ideally datasets of at least 10-20 compounds spanning a few orders of 
magnitude in measured dissociation constants would be used as this would allow robust 
statistical analysis of the relevance of a prediction (i.e. it would be relatively unlikely 
that a given molecular modelling protocol would achieve good performance by chance 
if the dataset is sufficiently large). Datasets could be devised with the input of impartial 
experienced molecular modellers privy to the blinded data so the level of challenge 
posed by a given dataset may be anticipated. For instance the markedly different 
topology of compound 60 in set 3 could have been expected to pose considerable 
difficulties for a relative free energy calculation protocol. Arguably efforts are better 
spent validating initially methodologies on cases that are perceived as less challenging. 
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Ultimately molecular modelling protocols should handle robustly both docking and 
scoring aspects for reliable routine use; however there is merit in constructing datasets 
that stress-test specific methodological aspects, and incrementally validate the domain 
of applicability of a protocol. Careful design of futures challenges is a difficult but 
important task that should encourage the community to explore different source of 
molecular modelling errors in a more controlled fashion.  
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